VA-DXC-TECHNOLOGY
15.1.2019 15:02:11 CET | Business Wire | Press release
A vast majority of businesses will increase their investments in digital technology over the coming year, and many expect IT modernization to fuel future transformation efforts that lead to cost savings and greater profitability. These are some of the findings from a new global survey conducted by The Economist Intelligence Unit (EIU) and commissioned by DXC Technology (NYSE: DXC), the world’s leading independent, end-to-end IT services company.
The study, “2019: The Year of Digital Decisions ,” explores how companies define digital transformation and the resulting business outcomes. Significantly, the report reveals that more than eight in ten survey respondents (83 percent) expect their organizations to increase their digital investments in 2019. And more than 40 percent of respondents predict that their organizations will increase their investments by 11 percent or more.
Currently, approximately half of companies surveyed have digitally enabled just three key organizational functions, according to the research. When asked to cite the top barriers to transformation, more than one-third (35 percent) of respondents flagged “cost or lack of funding,” second only to security concerns (40 percent).
However, most companies surveyed (76 percent) expect the cost savings from IT services modernization to help fund their digital strategy. Within the next three years, companies intend to greatly ramp up their efforts, and more than half of respondents (58 percent) expect every business unit to be digitally enabled in the next three years.
“Companies overwhelmingly recognize that digital innovation is now a requirement for them to compete and succeed,” said Dan Hushon , senior vice president and chief technology officer, DXC Technology. “The survey findings point to perhaps the most rapid, dramatic and sophisticated effort at reinvention that major businesses have attempted in many decades, and those surveyed are committed to investing to make digital happen.”
Survey respondents also linked digital transformation to profits. More than two-thirds (68 percent) say the annual profitability of their organizations has increased over the past three years thanks to their organizations’ digital strategy, and 74 percent say they expect it to rise over the next three years.
“We strongly believe that we can make the customer experience easier and simpler while leading to better outcomes through digital technology, and that will continue to drive our market share,” said survey report interviewee Neesha Hathi, executive vice president and chief digital officer at Charles Schwab. “Digital transformation also helps us scale our services while driving down costs for our clients.”
Digital decision drivers
The report reveals what companies aim to achieve by digitally remaking themselves, as well as the challenges they must overcome and the cultural changes they need to make. Other key findings include:
- Digital and business strategy formulation are completely or almost completely aligned at 72 percent of companies.
- Three-fourths (75 percent) of respondents say digital transformation will lead to greater agility, and 76 percent report that modern digital IT infrastructures better position their companies to produce value for their stakeholders.
- Approximately one-third (33 percent) of respondents say the lack of a tech-savvy workforce is a barrier to transformation.
- Nearly three-fourths (72 percent) of companies agree that a change in culture is necessary to digitally transform any organization. That figure is even higher for companies in developing regions and those that have implemented digital strategies only in the past two years.
“Our research indicates that digital strategy will continue to be a major area of investment – amounting to a dramatic effort at corporate reinvention. But getting it right will be a continuing challenge,” said Gilda Stahl, managing editor, thought leadership, at The Economist Intelligence Unit. “Defining your digital strategy clearly, ensuring digital literacy in every relevant role and recruiting digital-savvy employees are all essential to guaranteeing that digital investment yields positive business outcomes.”
Key regional and industry trends
- Companies that are further advanced – for example, those headquartered in North America and Europe and those in the financial services and manufacturing industries – tend to place greater emphasis on cross-functional collaboration, possibly because this helps them to optimize the digital investments they’ve already made.
- Financial services companies are more likely to stress AI/machine learning and blockchain while, for manufacturing companies, cloud computing and IoT are especially important.
- Social media is a somewhat higher priority for retailers than for other industries, given the importance to them of developing digital channels for sales and marketing. These tools play a growing role at marketing and communications firms as well.
Methodology
The Economist Intelligence Unit surveyed 621 senior executives in September and October 2018 to discover where companies are in their digital development and what they want to achieve with digital transformation. Respondents were members of the C-suite or held other senior leadership roles, including executive vice presidents, managing directors, and directors. Companies surveyed ranged in size from US$500 million to US$5 billion or more in annual revenue. Respondents were widely distributed across functions and industries — healthcare, manufacturing, retail and insurance are the biggest sectors represented.
Resources:
- 2019: The Year of Digital Decisions report
- Infographic: “Fostering an enterprise digital culture”
- Blog post: “Survey: Companies poised to go all-in on digital transformation in 2019”
- Follow DXC Technology on Twitter: https://twitter.com/DXCTechnology
- Join the conversation: #DXCDigitalDirections
About DXC Technology
As the world's leading independent, end-to-end IT services company, DXC Technology (NYSE: DXC) leads digital transformations for clients by modernizing and integrating their mainstream IT, and by deploying digital solutions at scale to produce better business outcomes. The company’s technology independence, global talent, and extensive partner network enable 6,000 private and public-sector clients in 70 countries to thrive on change. DXC is a recognized leader in corporate responsibility. For more information, visit dxc.technology and explore THRIVE , DXC’s digital destination for changemakers and innovators.
About The Economist Intelligence Unit
The Economist Intelligence Unit (EIU) is the research and analysis division of The Economist Group, the sister company to The Economist newspaper. Created in 1946, EIU has nearly 70 years’ experience in helping businesses, financial firms and governments to understand how the world is changing and how that creates opportunities to be seized and risks to be managed.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190115005239/en/
Contact:
Allison Wilson, Corporate Media Relations +1.352.502.9539, dwilson215@dxc.com
Donna Jenks, Corporate Media Relations +1.630.306.9989, donna.jenks@dxc.com
Jonathan Ford, Investor Relations +1.703.245.9700, jonathan.ford@dxc.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release
Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
